Outcome of Patients With Bladder Cancer With pN+ Disease After Preoperative Chemotherapy and Radical Cystectomy

Urology

Volumn 73, Issue 1, 2009, Pages 147-152

  Kassouf, Wassim ^a   Agarwal, Piyush K ^a   Grossman, H Barton ^b   Leibovici, Dan ^c   Munsell, Mark F ^b   Siefker Radtke, Arlene ^b   Pisters, Louis L ^c   Swanson, David A ^c   Dinney, Colin P N ^b   Kamat, Ashish M ^b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; PLATINUM COMPLEX;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; CYSTECTOMY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 57849138409     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.07.035     Document Type: Article

References (14)

1. Neoadjuvant chemotherapy in invasive bladder cancer. A systematic review and meta-analysis. Lancet 361 (2003) 1927-1934
2. Grossman H.B., Natale R.B., Tangen C.M., et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349 (2003) 859-866
3. Millikan R., Dinney C., Swanson D., et al. Integrated therapy for locally advanced bladder cancer: Final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC. J Clin Oncol 19 (2001) 4005-4013
4. Herr H.W., Faulkner J.R., Grossman H.B., et al. Surgical factors influence bladder cancer outcomes: A Cooperative Group report. J Clin Oncol 22 (2004) 2781-2789
5. Stein J.P., Cai J., Groshen S., et al. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: Concept of lymph node density. J Urol 170 (2003) 35-41
6. Vieweg J., Gschwend J.E., Herr H.W., et al. Pelvic lymph node dissection can be curative in patients with node positive bladder cancer. J Urol 161 (1999) 449-454
7. Abdel-Latif M., Abol-Enein H., El-Baz M., et al. Nodal involvement in bladder cancer cases treated with radical cystectomy: Incidence and prognosis. J Urol 172 (2004) 85-89
8. Winquist E., Kirchner T.S., Segal R., et al. Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: A systematic review and meta-analysis. J Urol 171 (2004) 561-569
9. Kassouf W., Leibovici D., Munsell M.F., et al. Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy. J Urol 176 (2006) 53-57
10. Stockle M., Meyenburg W., Wellek S., et al. Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): Improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy-Results of a controlled prospective study. J Urol 148 (1992) 302-307
11. Bono A.V., Benvenuti C., Reali L., et al., Italian Uro-Oncologic Cooperative Group. Adjuvant chemotherapy in advanced bladder cancer. Prog Clin Biol Res 303 (1989) 533-540
12. Freiha F., Reese J., and Torti F.M. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol 155 (1996) 495-500
13. Studer U.E., Bacchi M., Biedermann C., et al. Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: Results of a prospective randomized trial. J Urol 152 (1994) 81-84
14. Skinner D.G., Daniels J.R., Russell C.A., et al. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: A prospective comparative trial. J Urol 145 (1991) 459-467